Literature DB >> 24146406

Evaluation of prenylated peptides for use in cellular imaging and biochemical analysis.

Joshua D Ochocki1, Urule Igbavboa, W Gibson Wood, Edgar A Arriaga, Elizabeth V Wattenberg, Mark D Distefano.   

Abstract

Protein prenylation involves the addition of a farnesyl (C15) or geranylgeranyl (C20) isoprenoid moiety onto the C-terminus of approximately 2 % of all mammalian proteins. This hydrophobic modification serves to direct membrane association of the protein. Due to the finding that the oncogenic protein Ras is naturally prenylated, several researchers have developed inhibitors of the prenyltransferase enzymes as cancer therapeutics. Despite numerous studies on the enzymology of prenylation in vitro, many questions remain about the process of prenylation in living cells. Using a combination of flow cytometry and confocal microscopy, we have shown that synthetic fluorescently labeled prenylated peptides enter a variety of different cell types. Additionally, using capillary electrophoresis we have shown that these peptides can be detected in minute quantities from lysates of cells treated with these peptides. This method will allow for further study of the enzymology of protein prenylation in living cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24146406      PMCID: PMC4318554          DOI: 10.1007/978-1-62703-673-3_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

Review 1.  Biochemistry of protein prenylation.

Authors:  P J Casey
Journal:  J Lipid Res       Date:  1992-12       Impact factor: 5.922

Review 2.  Protein isoprenylation and methylation at carboxyl-terminal cysteine residues.

Authors:  S Clarke
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

3.  Quantitation of prenylcysteines by a selective cleavage reaction.

Authors:  W W Epstein; D Lever; L M Leining; E Bruenger; H C Rilling
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 4.  Tailoring Ras-pathway--inhibitor combinations for cancer therapy.

Authors:  Roy Blum; Yoel Kloog
Journal:  Drug Resist Updat       Date:  2005-12-13       Impact factor: 18.500

Review 5.  Isoprenoids and Alzheimer's disease: a complex relationship.

Authors:  S L Cole; R Vassar
Journal:  Neurobiol Dis       Date:  2006-01-10       Impact factor: 5.996

Review 6.  Protein prenylation: molecular mechanisms and functional consequences.

Authors:  F L Zhang; P J Casey
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

Review 7.  Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem.

Authors:  Sérgio F Sousa; Pedro A Fernandes; Maria João Ramos
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 8.  Farnesyltransferase inhibitors as anticancer agents: current status.

Authors:  Kuichun Zhu; Andrew D Hamilton; Saïd M Sebti
Journal:  Curr Opin Investig Drugs       Date:  2003-12

Review 9.  Development of farnesyltransferase inhibitors for clinical cancer therapy: focus on hematologic malignancies.

Authors:  Judith E Karp; Jeffrey E Lancet
Journal:  Cancer Invest       Date:  2007-09       Impact factor: 2.176

10.  Statins reduce amyloid-beta production through inhibition of protein isoprenylation.

Authors:  Stephen M Ostrowski; Brandy L Wilkinson; Todd E Golde; Gary Landreth
Journal:  J Biol Chem       Date:  2007-07-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.